These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16270771)

  • 1. Unusual presentations of differentiated thyroid cancer: analysis of 55 cases from North India.
    Bhansali A; Dutta P; Reddy KS; Masoodi SR; Radotra BD; Kumar V; Mittal BR
    Ann Saudi Med; 2005; 25(5):428-32. PubMed ID: 16270771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and treatment of differentiated thyroid carcinoma].
    Mora J
    Rev Esp Med Nucl; 2003; 22(5):349-59; quiz 360-2. PubMed ID: 14534014
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of thyroid cancer patients with favorable prognostic indicators.
    Leboulleux S; Baudin E; Schlumberger M
    Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
    [No Abstract]   [Full Text] [Related]  

  • 7. Follicular thyroid carcinoma: From diagnosis to treatment.
    Lin JD; Chao TC
    Endocr J; 2006 Aug; 53(4):441-8. PubMed ID: 16807500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
    Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
    Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of differentiated thyroid cancer of the follicular epithelium.
    Pacini F
    Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant goiter--thyroid cancer].
    Reiners C; Dietlein M; Luster M
    Dtsch Med Wochenschr; 2008 Oct; 133(43):2215-28; quiz 2229-30. PubMed ID: 18924056
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
    Czarniecka A; Włoch J; Lange D
    Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of intracranial metastases of differentiated carcinoma of thyroid.
    Biswal BM; Bal CS; Sandhu MS; Padhy AK; Rath GK
    J Neurooncol; 1994; 22(1):77-81. PubMed ID: 7714554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis.
    Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C
    World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.